Product image of Lenirit Micosi (Clotrimazole) supplied by GNH India

Lenirit Micosi

Active Ingredient:
Clotrimazole
Origin:
EU

Lenirit Micosi (Clotrimazole)

Clotrimazole, the active ingredient in Lenirit Micosi, is an imidazole antifungal presented as a topical formulation for cutaneous use. It treats superficial fungal infections such as athlete’s foot, ringworm, candidal skin infections and intertrigo in both adults and children. It is available without prescription in many European markets and is formulated for easy application to affected skin areas.

GNH India supplies Lenirit Micosi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions.

Manufacturer / TM Owner

Eg S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Clotrimazole is used to treat fungal skin infections by targeting dermatophytes and yeasts.

  • Tinea pedis: alleviates itching and clears infection of the feet.
  • Tinea corporis: reduces rash and eliminates the causative fungus on the body.
  • Candidiasis: treats cutaneous yeast infections, relieving redness and irritation.
  • Intertrigo: controls fungal overgrowth in skin folds, improving comfort.

How It Works

  • Clotrimazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key component of the ergosterol biosynthesis pathway. By blocking this enzyme, the drug prevents the formation of ergosterol, an essential sterol for fungal cell membrane integrity, leading to increased membrane permeability and ultimately fungal cell death. The disruption of membrane synthesis impairs fungal growth and replication, providing a fungistatic effect at lower concentrations and a fungicidal effect with prolonged exposure.

Side Effects

Topical clotrimazole may cause local skin reactions and, in rare cases, systemic adverse events.

Common Side Effects

  • Burning sensation at application site.
  • Itching or mild irritation.
  • Redness or erythema.
  • Dryness or peeling of the skin.

Serious or Rare Side Effects

  • Allergic contact dermatitis.
  • Swelling of the face, lips or tongue.
  • Severe skin blistering.
  • Systemic hypersensitivity reactions.

Precautions & Warnings

Before using Lenirit Micosi, observe the following precautions to ensure safe and effective treatment.

  • Avoid application on broken or inflamed skin: limit use to intact epidermis unless directed by a healthcare professional.
  • Do not use on mucous membranes or eyes: clotrimazole is intended for external skin only.
  • Monitor for signs of allergic reaction: discontinue and seek medical advice if rash or swelling develops.
  • Use with caution in children under two years: consult a pediatrician before treatment.
  • Pregnant or breastfeeding women: discuss risks with a healthcare provider before use.
  • Store at ambient temperature: keep the product in its original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Clotrimazole can interact with certain topical agents and systemic drugs; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Concurrent use with other topical antifungals: may increase local irritation.
  • Combination with corticosteroid creams: can mask infection signs and delay healing.

Moderate Interactions (Monitor Closely)

  • Systemic azole antifungals (e.g., itraconazole, fluconazole): may increase overall azole exposure.
  • Warfarin: clotrimazole may potentiate anticoagulant effect, monitor INR.
  • Oral antihistamines: may enhance sedation if extensive skin absorption occurs.

Frequently Asked Questions

Lenirit Micosi is indicated for the topical treatment of superficial fungal infections such as athlete’s foot (tinea pedis), body ringworm (tinea corporis), cutaneous candidiasis and intertrigo. The medication targets the fungi that cause these skin conditions, helping to relieve symptoms and clear the infection.

Clotrimazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Inhibiting this pathway disrupts membrane integrity, leading to increased permeability and ultimately stopping fungal growth or causing cell death.

The dosage and frequency of Lenirit Micosi are set by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Patients should follow the prescriber’s instructions and the product label carefully.

Safety data for clotrimazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lenirit Micosi.

To place an order, submit an enquiry on the Lenirit Micosi product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Clotrimazole, the active ingredient in Lenirit Micosi, belongs to the imidazole class and is primarily fungistatic, whereas terbinafine is an allylamine with a fungicidal profile. Both are effective for dermatophyte infections, but terbinafine often requires a shorter treatment course. Choice depends on physician preference, infection type and patient tolerance.

Store Lenirit Micosi at ambient temperature, preferably below 25 °C. Keep the tube or container in its original packaging, protect it from moisture, direct sunlight and extreme heat to maintain product stability.

Clean and dry the affected skin area before applying a thin layer of Lenirit Micosi. Gently rub it in until it disappears, typically twice daily or as directed by the prescriber. Continue use for the full course recommended, even if symptoms improve early.

Although rare, serious adverse reactions can include allergic contact dermatitis, facial or oral swelling, and severe skin blistering. If any of these signs appear, discontinue use immediately and seek medical attention.

Lenirit Micosi should be avoided in individuals with a known hypersensitivity to clotrimazole or any other component of the formulation. It is also not recommended for use on mucous membranes, the eyes, or on extensively damaged skin without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clotrimazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT